课题基金 / 基金详情

SDUDIES OF HIGH MOLECULAR SUBSTANCE- SOD CONJUGATE ON PREVENSION OF HEPATIC ISCHEMLA-REPERFUSION INJURY AND HEPATIC MICROCIRCULATION

SDUDIES OF HIGH MOLECULAR SUBSTANCE- SOD CONJUGATE ON PREVENSION OF HEPATIC ISCHEMLA-REPERFUSION INJURY AND HEPATIC MICROCIRCULATION
高分子物质-SOD结合物预防肝缺血再灌注损伤及肝微循环的研究
批准号:
08671410
负责人:
TODOROKI Takeshi
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

TODOROKI Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A protective effects of the SOD (superoxide dismutase)-DIVEMA(divinyl ether and maleic anhydride) conjugate on hepatic ischemia-reperfusion injury was demonstrated. Twenty min. of normothermotic ischemia was induced by clamping the portal triad of Sprangue-Dawley rats. SOD, SOD-DIVEMA, or physiologic NaCl was administered 5 min. prior to reperfusion. Hepatic microcirculation was obserbed during the 120 min. reperfusion period using intravital-fluoresent microscope and events were'recorded to video system for the later analysis. SOD- DIVEMA restored the sinusoidal perfusion rate (98.5% for SOD-DIVEMA vs. 98.0% for no-ischemia, 65.5% for NaCl and 81.5% for SOD administration), and reduced the number of leukocyte stagnant in the acini (12.3 cells/lobule for SOD- DIVEMA vs. 4.4 for no-ischemia, 36.6 for NaCi, 27.7 for SOD administration) and adherent it in the postsinusoidal venule (40.0 cells/mm^2 for SOD-DWEMA vs. 55.0 for no-ischemia, 417 for NaCl and 253 for SOD administration) significantly in comparing control studies. Furthermore, SOD-DIVEMA maintained postischemic hepatocellular integrity . The SOD-DIVEMA treated group maintained significantly higher serum level of SOD activity after 120 min. of reperfusion than the SOD treated group ; 33.0 U/ml vs. 8.6 U/mi. The demonstration of the most beneficial efficacy of SOD-DIVEMA after the period of 120 min. of repercussion indicats a longer intravascular SOD activity than sole SOD administration.
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
轟 健: "胆嚢癌切除の予後向上を目指した集学的治療とその成績" 消化器外科. 22. 89-98 (1999)
Ken Todoroki:“旨在改善胆囊癌切除预后的多学科治疗及其结果”《胃肠外科》22. 89-98 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeshi Hirano: "Anti-inflammatory effect of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride against rat re-expansion pulmonary edema" Journal of Comtrolled Release. 48. 131-139 (1997)
Takeshi Hirano:“超氧化物歧化酶与二乙烯基醚和马来酸酐的共聚物的缀合物对大鼠复张性肺水肿的抗炎作用”《受控释放杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takeshi Todoroki: "Outcome of Aggressive Treatment of Satge IV Gallbladder Cancer and Predictors of Survival" Hepato-Gastroenterology. (in press).
Takeshi Todoroki:“Satge IV 胆囊癌积极治疗的结果和生存预测”肝胃肠病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tadashi Kondo: "Applicatiohn of a novel Method for Subsequent Evaluation of Sinusoids and Postsinusoidal Venules after Ischemia-Reperfusion Injury of Rat Liver" European Surgical Research. 30. 252-258 (1998)
Tadashi Kondo:“应用一种新方法对大鼠肝脏缺血再灌注损伤后的正弦波和窦后小静脉进行后续评估”欧洲外科研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
40
    Mucin glycoproteins in human gallbladder carcinoma and their biological effects on tumor invasion and metastasis capability.
    • 批准号:
      13671279
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2001
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    Protection of hepatic microcirculatory disturbance due to the ischemia-reperfusion injury
    • 批准号:
      13671278
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    The effect of TAK-O44 combined with SOD-DIVEMA on ischemia reperfusion liver injury.
    • 批准号:
      11671208
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    Prevention of reperfusion liver injury by SOD-(DIVEMA) conjugate
    • 批准号:
      06455003
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.42万
    • 财政年份:
      1994
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    国内基金
    海外基金
    锌通过调节 SoxR 中[2Fe-2S]簇稳态调控肠杆菌科 SoxS-SOD 轴参与氧化应激机制及抗菌应用研究
    • 批准号:
      ZCLZ26C0101
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭国强
    • 依托单位:
    过表达GABPA靶向激活SOD3减轻氧化应激保护小鼠免受强直性脊柱炎导致的损伤
    • 批准号:
      2026JJ82278
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      吴文欣
    • 依托单位:
    柳穿鱼黄素通过PPARγ/SOD2轴抑制铁死亡减轻小鼠胆汁淤积性肝损伤的机制研究
    植物乳杆菌CCFM8661通过PGC-1α/SIRT3/SOD2通路在铅致肾损伤中的保护作用和机制研究
    • 批准号:
      2025JJ80782
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      詹丽超
    • 依托单位: